Virusight Diagnostic is a mutual collaboration between Newsight Imaging and Sheba Medical Center – that joined together to develop the world’s fastest COVID-19 test. Using Newsight's unique spectral technology, Virusight’s AI software allows for several pathogens’ diagnosis in human samples within seconds. The technology was already granted the CE Mark and is in the process of global commercialization, active in over 40 countries worldwide.
About Virusight
Virusight is an AI software company, using Newsight’s unique spectral analysis technology, for pathogens diagnosis.
Founded in 2020 following the Coronavirus pandemic, the company is a result of mutual collaboration between Newsight Imaging and Sheba Hospital – ranked as one of the top 10 hospitals in the world by Newsweek.
Virusight is developing revolutionary COVID-19 rapid tests, obtained by the SpectraLIT™ - Newsight Imaging’s unique innovative spectrometer device that supports both swabs and non-invasive oral rinse. The technology allows for an affordable, and portable solution that provides accurate results within seconds.
Real-Time Pathogens Diagnosis
Virusight’s technology uses AI modules to classify spectral signatures of different pathogens found in body fluids, obtained by the SpectraLIT™. The solution detects the spectral signature of the subject’s reaction to the virus and using Virusight’s AI and machine learning technology could immediately differentiate between sick and healthy patients.
Accurate rapid testing at-home or any point of care will assist to prevent virus spread and allow treating patients on time and could save human lives.
Regulations and Worldwide Pilots
The technology was already granted the CE Mark and is waiting on FDA EUA and other regulatory approvals.
Virusight is in the process of global commercialization, and currently conducting clinical trials and pilots in leading hospitals worldwide. Being active in over 40 countries around the world, the company’s mission is to enable access to immediate, affordable testing, everywhere.
Mutations and Other Viruses
Using AI, Virusight’s solution improves the accuracy of the results over time, and can easily be adapted to mutations using a simple firmware update. The Solution has been proven to identify other tropical pathogens and is currently in research of other pathogens. Looking forward to a post-Coronavirus era, Virusight aims to become a leading player in the field of immediate pathogens detection, at any point of care.